Birdwatch Note Rating
2023-05-20 01:47:42 UTC - NOT_HELPFUL
Rated by Participant: 36BD71126E99AD5718B10FDA37E6B6521E4516991A55D47AC7BA0ACD061F1DB7
Participant Details
Original Note:
The reactogenicity subset consisted of 8,183 persons. Severe disease subset was the entire cohort (N=43,355) The severe disease endpoint was 30-1 in favor of placebo for 96.7% reduction in 6 month follow up data https://www.nejm.org/doi/suppl/10.1056/NEJMoa2034577/suppl_file/nejmoa2034577_appendix.pdf https://www.nejm.org/doi/full/10.1056/nejmoa2110345
All Note Details